BioCentury
ARTICLE | Clinical News

Fluticasone propionate/salmeterol MDPI: Phase III data

November 23, 2015 8:00 AM UTC

Top-line data from the open-label, U.S. Phase III Study FSS-AS-305 in 1,087 adolescent and adult patients with persistent asthma showed that twice-daily 100/12.5 and 200/12.5 ug fluticasone propionate...